Collaborative influenza vaccine innovation centers (CIVICS) component B: vaccine manufacturing and toxicology core

Active Definitive Contract Awarded Last action

Contract number
75N93019C00053
Awardee
Awarding agency
Obligated
$77,629,982

Award facts

Opportunity
Contract value 55% obligated
  • $77,629,981.68 Current, with exercised options
  • $140,772,186.68 Potential, with all options
Completion date 71% complete
Current and potential, with all options
Set-aside
No set-aside
Competition
Full and Open Competition · 2 offers Negotiated Proposal / Quote
Pricing
Cost No Fee
Place of performance
Durham, NC 27705, USA
Legislative mandates

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Funding Only Action P00034 -$580,963
Supplemental Agreement for work within scope P00033 · Civics, component B $11,392
Funding Only Action P00032 -$827,408
Supplemental Agreement for work within scope P00031 $1,061,854
Exercise an Option P00030 $529,176
Supplemental Agreement for work within scope P00029 $0
Supplemental Agreement for work within scope P00028 $0
Funding Only Action P00027 -$1,072,513
Supplemental Agreement for work within scope P00026 $3,680,889
Exercise an Option P00025 $7,105,857
Exercise an Option P00024 $312,633
Supplemental Agreement for work within scope P00023 $0
Supplemental Agreement for work within scope P00022 $0
Exercise an Option P00021 $9,227,951
Funding Only Action P00020 $889,393
Funding Only Action P00019 $1,799,736
Funding Only Action P00018 $482,144
Supplemental Agreement for work within scope P00017 $0
Exercise an Option P00016 $672,524
Exercise an Option P00015 $6,479,034
Funding Only Action P00014 $321,765
Exercise an Option P00013 $634,372
Funding Only Action P00012 $1,004,921
Other Administrative Action P00011 $0
Exercise an Option P00010 · 19C00053; collaborative influenza vaccine innovation centers (CIVICS) component B: vaccine manufacturing and toxicology core. The purpose of this modification… $4,000,000
Other Administrative Action P00009 $0
Funding Only Action P00008 · 19C00053; collaborative influenza vaccine innovation centers (CIVICS) component B: vaccine manufacturing and toxicology core. The purpose of this modification… $1,863,113
Other Administrative Action P00007 · The purpose of this modification is to extend the periods of performance of option 26.a and option 33 and update various articles and clauses. $0
Funding Only Action P00006 · The purpose of this modification is to add funds to option 8 and update various articles and clauses. $3,965,281
Exercise an Option P00005 · The purpose of this modification is to exercise options 17.a and 17.B, update key personnel, and update various articles and clauses $1,309,634
Change Order P00004 · The purpose of this modification is to revise clauses in accordance with interim far rule 2019-009, effective august 13, 2020, correct line item numbers and… $11,947,956
Exercise an Option P00003 · The purpose of this modification is to exercise option 9 and update various articles and clauses. $7,219,992
Exercise an Option P00002 · The purpose of this modification is to reserve option 14, add options 26-39, exercise options 1, 26.a, and 33, update the key personnel and statement of work,… $1,813,041
Other Administrative Action P00001 $0
Original award $13,778,209
Show all 35

About this award

The National Institute of Allergy and Infectious Diseases awarded a $140.8 million definitive contract to Duke University for the Collaborative Influenza Vaccine Innovation Centers (CIVICS) Component B: Vaccine Manufacturing and Toxicology Core on August 26, 2019, under cost–no–fee pricing with no set-aside.

Place of performance is Durham, NC. The contract extends through September 30, 2029. The originating solicitation calls for vaccine manufacturing and toxicology support under CIVICS Component B.

Government-invoiced labor activity shows 20.8 FTEs in the most recent fiscal year (FY2025), with $21.5 million invoiced that year. Across the contract's reported history, invoiced amounts ranged from $1.8 million (FY2020) to $21.5 million (FY2025), with contractor hours peaking at 59,823 in FY2022 before declining. Derived government-paid hourly rates rose substantially over time, from $236.88 per hour in FY2021 to $1,204.05 per hour in FY2024. Duke University self-performed all reported work; no subcontractors were engaged in SCI-reportable labor.

Quick answers

Who was awarded contract 75N93019C00053?

75N93019C00053 was awarded to Duke University by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on August 26, 2019.

How much is contract 75N93019C00053 worth?

The government has obligated $77,629,982 on 75N93019C00053. Its potential value, with all options, is $140,772,187.

Was contract 75N93019C00053 competed?

The extent of competition for 75N93019C00053 was full and open competition. The government received 2 offers.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award